Patents by Inventor Ash BAHL

Ash BAHL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 4-[[(7-aminopyrazolo[1,5-a]pyrimidin-5-yl)amino]methyl]piperidin-3-ol compounds as CDK inhibitors
    Patent number: 11857552
    Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain 4-[[(7-aminopyrazolo[1,5-a]pyrimidin-5-yl)amino]methyl]piperidin-3-ol compounds (referred to herein as “APPAMP compounds”) that, inter alia, inhibit (e.g., selectively inhibit) CDK (e.g., CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8, CDK9, CDK10, CDK11, CDK12, CDK13, etc.).
    Type: Grant
    Filed: September 20, 2018
    Date of Patent: January 2, 2024
    Assignee: CARRICK THERAPEUTICS LIMITED
    Inventors: Ash Bahl, Ed Ainscow, Alexander Bondke, Anthony G. M. Barrett, Mihiro Sunose, Jason John Shiers, Kamaldeep Chohan
  • 4-[[(7-AMINOPYRAZOLO[1,5-A]PYRIMIDIN-5-YL)AMINO]METHYL]PIPERIDIN-3-OL COMPOUNDS AS CDK INHIBITORS
    Publication number: 20200345736
    Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain 4-[[(7-aminopyrazolo[1,5-a]pyrimidin-5-yl)amino]methyl]piperidin-3-ol compounds (referred to herein as “APPAMP compounds”) that, inter alia, inhibit (e.g., selectively inhibit) CDK (e.g., CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8, CDK9, CDK10, CDK11, CDK12, CDK13, etc.).
    Type: Application
    Filed: September 20, 2018
    Publication date: November 5, 2020
    Inventors: Ash BAHL, Ed AINSCOW, Alexander BONDKE, Anthony G.M. BARRETT, Mihiro SUNOSE, Jason John SHIERS, Kamaldeep CHOHAN